Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel Free XBI Stock Alerts

SPDR S&P Biotech ETF (XBI) News Today

SPDR S&P Biotech ETF logo
$168.23 -0.16 (-0.10%)
Closing price 04:10 PM Eastern
Extended Trading
$168.22 -0.01 (-0.01%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

SPDR S&P Biotech ETF Latest News

After-hours Gainers: HOWL Jumps 90%, MODD To Begin Pivot Pump Rollout, BIVI Awaits Long COVID Data
August 20, 2026  |  rttnews.comhttps://www.rttnews.com/3682870/after-hours-gainers-howl-jumps-90-modd-to-begin-pivot-pump-rollout-bivi-awaits-long-covid-data.aspx?type=ts
XBI: Biotech's Breakthrough Moment Happend This Week (Upgrade)
August 20, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4938868-xbi-biotechs-breakthrough-moment-happend-this-week-upgrade
XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?
August 19, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/xbi-vs-fbt-broad-biotech-120501716.html
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI?
August 18, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/healthcare-etf-better-buy-vanecks-180250312.html
iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond?
August 8, 2026  |  fool.comhttps://www.fool.com/coverage/etfs/2026/08/08/ishares-global-healthcare-etf-vs-state-street-spdr-biotech-etf-which-healthcare-focused-fund-will-bring-you-profits-in-2026-and-beyond/
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks
August 7, 2026  |  barrons.comhttps://www.barrons.com/articles/biotech-pharma-merck-novartis-bristol-myers-stocks-1b626dfc
ETF Showdown: XBI vs PBE, Which Biotech Fund Wins?
July 24, 2026  |  247wallst.comhttps://247wallst.com/investing/etf/2026/07/24/etf-showdown-xbi-vs-pbe-which-biotech-fund-wins/?utm_source=snapi
Biotech remains compelling even after major comeback. Here’s what investors say
July 22, 2026  |  cnbc.comhttps://www.cnbc.com/2026/07/22/biotech-remains-compelling-even-after-major-comeback-heres-what-investors-say-.html
Buying Biotech's Policy Discount With XBI And IBB: Most 'Feared' Nation Policy, Less-Than-Feared Damage
July 21, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4923894-buying-biotechs-policy-discount-with-xbi-and-ibb-most-feared-nation-policy-less-than-feared-damage
Has the bull market shifted to biotech stocks?
July 18, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/has-the-bull-market-shifted-to-biotech-stocks/ar-AA288HkG
This ETF Is Up Nearly 17% in a Month and Doesn't Own a Single Share of Nvidia
July 6, 2026  |  247wallst.comhttps://247wallst.com/investing/etf/2026/07/06/this-etf-is-up-nearly-17-in-a-month-and-doesnt-own-a-single-share-of-nvidia/?utm_source=snapi
XBI Ignored The Market's Downturn
June 30, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/xbi-ignored-markets-downturn-235307139.html
This Biotech ETF Has Almost Doubled in 13 Months. Money Is Flowing In.
June 26, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/this-biotech-etf-has-almost-doubled-in-13-months-money-is-flowing-in/ar-AA26D5av
XBI: A "Hidden" ETF Up +70% In 1 Year.
June 20, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4916472-xbi-a-hidden-etf-up-plus-70-percent-in-1-year
Wall Street Technician Declares Financials, Industrials, and Biotech Poised for Breakouts. 3 ETFs Could Soar.
June 20, 2026  |  247wallst.comhttps://247wallst.com/investing/2026/06/20/wall-street-technician-declares-financials-industrials-and-biotech-poised-for-breakouts-3-etfs-could-soar/?utm_source=snapi
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?
June 17, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/ishares-pharma-etf-ihe-spdrs-200642140.html
State Street SPDR S&P Biotech ETF
June 16, 2026  |  barrons.comhttps://www.barrons.com/market-data/funds/xbi
Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC
June 16, 2026  |  cnbc.comhttps://www.cnbc.com/2026/06/16/biotech-deals-ipo-pharma-dealmaking-2026.html
Biotech stocks are losing momentum despite rising M&A activity
June 10, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/biotech-stocks-are-losing-momentum-despite-rising-m-a-activity/ar-AA25dCwB
A laboratory desk displays a tablet with health icons, a microscope, DNA model, and hourglass, with researchers working in the background.
3 Longevity ETFs to Buy and Hold (and Hold)
The size of the longevity industry could roughly triple in the next decade, and these ETFs may help to provide access to a fast-growing space.
June 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/articles/3-longevity-etfs-to-buy-and-hold-and-hold/
‘Buying stuff like it's going out of fashion': Biotech M&A on track for best year since pre-Covid
June 4, 2026  |  cnbc.comhttps://www.cnbc.com/2026/06/04/biotech-ma-dealmaking-pharma-106-billion.html
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost
May 28, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/vht-vs-xbi-vanguard-health-122709081.html
Biotech Investors Are Tuning Out the MAHA Chaos
May 20, 2026  |  wsj.comhttps://www.wsj.com/tech/biotech/biotech-investors-are-tuning-out-the-maha-chaos-658b0480
Trade Tracker: Joe Terranova sells the biotech ETF XBI
May 19, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/trade-tracker-joe-terranova-sells-the-biotech-etf-xbi/vi-AA23zVxt
If You Hold This Healthcare ETF, You're Losing Big
May 19, 2026  |  247wallst.comhttps://247wallst.com/investing/2026/05/19/if-you-hold-this-healthcare-etf-youre-losing-big/?utm_source=snapi
2 Ways to Play the Big Pharma Patent Cliff
With hundreds of billions in sales on the line for drugs that will lose their patent exclusivity in the coming years, two biotech ETFs can help capitalize.
May 14, 2026  |  marketbeat.comhttps://www.marketbeat.com/originals/2-ways-to-play-the-big-pharma-patent-cliff/
Why this biotech ETF — the IBD stock of the day — just reentered its buy zone
May 4, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/why-this-biotech-etf-the-ibd-stock-of-the-day-just-reentered-its-buy-zone/ar-AA22niTh
Locking in a quick gain in this biotech ETF made room for better swing trades; here's why
May 1, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/locking-in-a-quick-gain-in-this-biotech-etf-made-room-for-better-swing-trades-heres-why/ar-AA22bMAX
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now
April 23, 2026  |  247wallst.comhttps://247wallst.com/investing/2026/04/23/equal-weight-etfs-are-the-play-for-small-cap-drug-development-heres-how-to-position-now/?utm_source=snapi
XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026
April 7, 2026  |  247wallst.comhttps://247wallst.com/investing/2026/04/07/xbi-vs-ibb-the-biotech-etf-showdown-that-analysts-say-has-a-clear-winner-in-2026/?utm_source=snapi
This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It.
April 3, 2026  |  247wallst.comhttps://247wallst.com/investing/2026/04/03/this-biotech-etf-is-still-well-below-its-2021-peak-analysts-say-that-is-exactly-why-to-buy-it/?utm_source=snapi
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead
March 28, 2026  |  247wallst.comhttps://247wallst.com/investing/2026/03/28/biotech-stocks-are-up-about-35-in-the-past-year-and-analysts-say-the-biggest-gains-are-still-ahead/?utm_source=snapi
XBI: Biotech M&A Has Been Hot, But Price Trends Have Cooled
March 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4882403-xbi-biotech-m-and-a-has-been-hot-but-price-trends-have-cooled
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now?
February 24, 2026  |  tipranks.comhttps://www.tipranks.com/news/is-the-spdr-sp-biotech-etf-xbi-a-strong-buy-right-now?utm_source=marketbeat.com&utm_medium=referral
Biotech stocks are among today's winners
January 22, 2026  |  marketwatch.comhttps://www.marketwatch.com/livecoverage/stock-market-today-dow-sp500-nasdaq-extend-rally-trump-greenland-pivot-pce-data-intel-earnings/card/biotech-stocks-are-among-today-s-winners-iHU6cJjgjJC2748siKTg
Funding for Risky Biotechs Is Returning
January 12, 2026  |  wsj.comhttps://www.wsj.com/tech/biotech/funding-for-risky-biotechs-is-returning-fc21ebe7
Biotech and pharma stocks tumble as investors race into energy
January 5, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/biotech-and-pharma-stocks-tumble-as-investors-race-into-energy/ar-AA1TCAgy
Biotech: Time For A Pause To Start 2026
January 2, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4856763-biotech-time-for-pause-to-start-2026
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
December 23, 2025  |  benzinga.comhttps://www.benzinga.com/etfs/sector-etfs/25/12/49570565/novo-nordisks-wegovy-pill-shakes-up-rivalry-with-eli-lilly-puts-health-care-etfs-in-focus?utm_source=snapi
2 Brilliant Biotech ETFs to Watch in 2026
December 14, 2025  |  247wallst.comhttps://247wallst.com/investing/2025/12/14/2-brilliant-biotech-etfs-to-watch-in-2026/?utm_source=snapi
State Street® SPDR® S&P® Biotech ETF
November 27, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/etfs/state-street-spdr-sp-biotech-etf-us78464a8707
Why biotech and drug stocks are on the mend even though the rest of the market is hurting
November 18, 2025  |  msn.comhttps://www.msn.com/en-us/money/markets/why-biotech-and-drug-stocks-are-on-the-mend-even-though-the-rest-of-the-market-is-hurting/ar-AA1QGMbs
Biotech Insiders Are Spending Billions. Trump Favors Less Oversight.
November 17, 2025  |  fool.comhttps://www.fool.com/investing/2025/11/17/biotech-insiders-are-spending-billions-trump-favor/
Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge.
November 17, 2025  |  fool.comhttps://www.fool.com/investing/2025/11/17/biotech-insiders-are-spending-billions-trump-favor/?source=iedfolrf0000001
XBI: Biotech Funding Condition Recovery Could Be Overdue
November 16, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4844362-xbi-biotech-funding-condition-recovery-could-be-overdue
XBI: An Equal Weight ETF On Biotech That Amplifies Its Speculative Component
November 16, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4844357-xbi-an-equal-weight-etf-on-biotech-that-amplifies-its-speculative-component
Daily ETF Flows: Biotech ETF 'XBI' In Demand
November 15, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/daily-etf-flows-biotech-etf-230004878.html?fr=sycsrp_catchall
Biotech Stocks Returned To Health And Offered Multiple Entries
October 24, 2025  |  investors.comhttps://www.investors.com/research/swing-trading/biotech-stocks-returned-to-health/
Analyst Says He’s Buying This Biotech ETF, Predicts ‘Multi-Year’ Breakout
October 21, 2025  |  insidermonkey.comhttps://www.insidermonkey.com/blog/analyst-says-hes-buying-this-biotech-etf-predicts-multi-year-breakout-1630274/
Biotech Is Finally Rallying. Why Mizuho’s Jared Holz Is Optimistic This Time.
October 17, 2025  |  msn.comhttps://www.msn.com/en-us/money/topstocks/biotech-is-finally-rallying-why-mizuho-s-jared-holz-is-optimistic-this-time/ar-AA1OGoyE

SPDR S&P Biotech ETF Media Mentions By Week

SPDR S&P Biotech ETF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

XBI
News Sentiment
▼
0.18

0.60
▲
Average

News Sentiment

SPDR S&P Biotech ETF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

XBI Articles
This Week
▼
1

1
▲
XBI Articles
Average Week

SPDR S&P Biotech ETF Trends on MarketBeat

This week vs. last week
New Followers
2
+100%
Searches
3
Page Views
1,917
-7%
Get SPDR S&P Biotech ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for SPDR S&P Biotech ETF dated 8/20/2026.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel